Men's Health studies

Our robust men’s health research program includes research scientists and clinicians at our Southern California medical centers. Several studies stem from the California Men’s Health Study, which evaluated risk factors for prostate cancer, benign prostatic hyperplasia, and erectile dysfunction in 80,000 Kaiser Permanente members in California. We evaluate new tests for prostate cancer screening and also evaluate quality of life for newly diagnosed prostate cancer patients, assess preventive services in prostate cancer survivors, and examine genetic and other factors associated with aggressive and fatal prostate cancer.

Identification of DNA methylation markers for risk of metastasis in localized prostate

The goal of this project is to develop DNA methylation marker-based prediction algorithms that will assist clinicians when providing therapeutic recommendations for men with localized prostate cancer.

Principal Investigator:

Chun Chao, PhD, MS

Funding Source:

National Institutes of Health (NIH)

Funding Years:

2015 - 2019

Research Categories:

,

OPATS: Outcomes of Prostate Cancer Androgen Deprivation Therapy Study

The goal is to assess fatal and morbid outcomes up to 15 years following androgen deprivation therapy for men initially diagnosed with localized prostate cancer.

Principal Investigator:

Reina Haque, PhD, MPH

Funding Source:

National Cancer Institute (NCI)

Funding Years:

2010 - 2014

Research Categories:

,

REPRISE 2: Is depression associated with prostate cancer progression?

This study examines if depression and its treatment can affect the course of prostate cancer.

Principal Investigator:

Reina Haque, PhD, MPH

Funding Source:

National Cancer Institute (NCI)

Funding Years:

2018 - 2020

Research Categories:

, ,